삼성서울병원

Ko En

Radiation Oncology Oh, Dong Ryul M.D

Expertise
Head and neck cancer, lymphoma, esophageal cancer, digital health care
Treament Schedule 10 月
DATE
TUE
01
WEB
02
THU
03
FRI
04
SAT
05
SUN
06
MON
07
TUE
08
WEB
09
THU
10
FRI
11
SAT
12
SUN
13
MON
14
TUE
15
WEB
16
THU
17
FRI
18
SAT
19
SUN
20
MON
21
TUE
22
WEB
23
THU
24
FRI
25
SAT
26
SUN
27
MON
28
TUE
29
WEB
30
THU
31
AM
PM
Treament Schedule 11 月
DATE
FRI
01
SAT
02
SUN
03
MON
04
TUE
05
WEB
06
THU
07
FRI
08
SAT
09
SUN
10
MON
11
TUE
12
WEB
13
THU
14
FRI
15
SAT
16
SUN
17
MON
18
TUE
19
WEB
20
THU
21
FRI
22
SAT
23
SUN
24
MON
25
TUE
26
WEB
27
THU
28
FRI
29
SAT
30
AM
PM

Medical Education

####~2017 Ph.D. Sungkunkwan university school of medicine, Korea
####~2007 M.S. Sungkunkwan university school of medicine, Korea
1997~2003 M.D. Sungkunkwan university school of medicine, Korea

Post-Graduate Training

Fellowship   2011~2013 Department of radiation oncology, Samsung medical center, Korea
Residency   2004~2008 Department of radiation oncology, Samsung medical center, Korea
Internship   2003~2004 Samsung medical Center, Korea

Professional Appointments

2018~Present Associate Professor Department of radiation oncology, Samsung medical center. Sungkyunkwan University School of Medicine
2018~Present Chief Department of radiation oncology, Samsung medical center. Korea
2014~2017 Assistant Professor Department of radiation oncology, Samsung medical center. Korea
2013~2014 Clinical Instructor Department of radiation oncology, Samsung medical center. Korea

Professional Memberships

2022~Present Board member The Korean Society of Medical Oncology
2021~Present Director at Large The Korean Society for Head & Neck Oncology
2019~Present Division Director Korean Radiation Oncology Group, Lymphoma group
2009~Present Membership The Korean Society for Radiation Oncology (KOSRO)

Selected Publications

  • J BONE ONCOL 2021 10.1016/j.jbo.2021.100368 Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases Kim1, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS
    View PubMed
  • J CACHEXIA SARCOPENIA MUSCLE 2021 10.1002/jcsm.12747 Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancer Yoon1, HG; Oh, D; Noh, JM; Cho, WK; Sun, JM; Kim, HK; Zo, JI; Shim, YM; Kim, K
    View PubMed
  • CANCERS 2021 10.3390/cancers13071549 Early Clinical Outcomes of Intensity Modulated Radiation Therapy/Intensity Modulated Proton Therapy Combination in Comparison with Intensity Modulated Radiation Therapy Alone in Oropharynx Cancer Patients Yoon1, HG; Ahn, YC; Oh, D; Noh, JM; Park, SG; Nam, H; Ju, SG; Kwon, D; Park, S
    View PubMed
  • KOREAN J INTERN MED 2021 10.3904/kjim.2019.161 Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancer Lim1, SH; Sun, JM; Hong, J; Oh, D; Ahn, YC; Chung, MK; Jeong, HS; Son, YI; Ahn, MJ; Baek, CH; Park, K
    View PubMed
  • ORAL ONCOL 2021 10.1016/j.oraloncology.2021.105180 Clinical features of post-radiation nasopharyngeal necrosis and their outcomes following surgical intervention in nasopharyngeal cancer patients Yang1, K; Ahn, YC; Nam, H; Hong, SD; Oh, D; Noh, JM
    View PubMed